Cargando…
The Synergistic Activity of Bortezomib and TIC10 against A2058 Melanoma Cells
Combination antitumor treatments are essential parts of modern tumor therapy as—compared to monotherapies—(i) they are more effective; (ii) the dose of the compounds can be reduced; and (iii) therefore the side effects are improved. Our research group previously demonstrated the antitumor character...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399995/ https://www.ncbi.nlm.nih.gov/pubmed/34451917 http://dx.doi.org/10.3390/ph14080820 |